Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer

Katrin J. Frank(TUM Klinikum), Sara Mainardi(The Netherlands Cancer Institute)

Cell Reports Medicine

November 1, 2022

10.1016/j.xcrm.2022.100815

Cited by 34

Related Papers

No related papers found

Powered by citation graph analysis